Topeka, KSNCT07483099Now EnrollingIRB Ready

Crohn Disease Clinical Trial in Topeka, KS

Access cutting-edge crohn disease treatment through this clinical trial at a research site in Topeka. Study-provided care at no cost to qualified participants.

Sponsored by Eli Lilly and Company

Quick Self-Assessment

See if you qualify for this Topeka location

Preparing your pre-screening questions…

Expert Care in Topeka

Access crohn disease specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related crohn disease treatment provided free

Apply for This Topeka Location

Check if you qualify for this crohn disease clinical trial in Topeka, KS

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Topeka

    Convenient for KS residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Topeka site if eligible
  4. 4Begin participation

About This Crohn Disease Study in Topeka

The main purpose of this study is to see how the safety and efficacy of a farnesoid X receptor (FXR) agonist (LY4395089), given together with mirikizumab compares with mirikizumab (alone) in adults with moderately to severely active Crohn's disease (CD). This study is part of the IIBD master protocol and will last approximately 62 weeks.

Sponsor: Eli Lilly and Company

Who Can Participate

Inclusion Criteria

Participants must meet all the inclusion criteria in the IIBD master protocol, except the UC-specific criteria. In addition, they must meet the criteria below:
Participants taking glucagon-like peptide-1 (GLP-1) receptor agonists (RAs), GLP-1/glucose-dependent insulinotropic polypeptide (GIP) RAs, GLP-1/glucagon (Gcg) RAs, GLP-1/GIP/Gcg RAs, or similar medications for approved indications will be permitted to enroll provided they are on a stable dose at the time of screening

Exclusion Criteria

Participants are excluded from the study if any of the exclusion criteria in the IIBD master protocol, except the UC-specific criteria apply, or if any of the following criteria apply:
Must not have a hepatic disease
Must not have a history of any other bone disease that affects bone metabolism
Must not have had any of the following within the past 180 days before screening:
acute myocardial infarction
cerebrovascular incident
hospitalization for unstable angina
hospitalization due to congestive heart failure, or
coronary revascularization
Must not have received or will need any other prohibited medications as specified in the protocol

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Topeka?

Yes, this clinical trial (NCT07483099) has an active research site in Topeka, KS that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Crohn Disease Treatment Options in Topeka, KS

If you're searching for crohn disease treatment options in Topeka, KS, this clinical trial (NCT07483099) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Topeka research site is actively enrolling participants for this clinical trial. You'll receive care from experienced crohn disease specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all crohn disease clinical trials near you to find additional studies recruiting in your area.

More Crohns Disease Trials in Topeka, KS

See all crohns disease clinical trials recruiting in Topeka — not just this study.

Browse Crohns Disease Trials in Topeka

Ready to Join in Topeka?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Topeka, KS